Similar articles

• [Experimental chloroquine myopathy--morphological and biochemical studies].

  Kumamoto T, Araki S, Toyoshima I, Fukuhara N. Kumamoto T, et al. Rinsho Shinkeigaku. 1984 May;24(5):505-12. Rinsho Shinkeigaku. 1984. PMID: 6478718 Japanese. No abstract available.
• [Experimental studies on the etiology of nitrofurane-induced polyneuropathy and histopathology of chlorochindiphosphate (Resochin) neuro-myopathy].

  Klinghardt GW. Klinghardt GW. Beitr Neurochir. 1970;16:55-61. Beitr Neurochir. 1970. PMID: 4246650 German. No abstract available.
• Skeletal muscle expression of clathrin and mannose 6-phosphate receptor in experimental chloroquine-induced myopathy.

  Masuda T, Ueyama H, Nakamura K, Jikumaru M, Toyoshima I, Kumamoto T. Masuda T, et al. Muscle Nerve. 2005 Apr;31(4):495-502. doi: 10.1002/mus.20288. Muscle Nerve. 2005. PMID: 15712280
• Chloroquine myopathy suggests that tau is degraded in lysosomes: implication for the formation of paired helical filaments in Alzheimer's disease.

  Oyama F, Murakami N, Ihara Y. Oyama F, et al. Neurosci Res. 1998 May;31(1):1-8. doi: 10.1016/s0168-0102(98)00020-0. Neurosci Res. 1998. PMID: 9704973 Review.
• Experimental neuropathology and clinical neurology of chloroquine side effects.

  Klinghardt GW. Klinghardt GW. Int J Neurol. 1978;11(4):331-41. Int J Neurol. 1978. PMID: 397203 Review. No abstract available.